Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04262817 · ClinicalTrials.gov registry record · Phase 1
The Interaction of Flavor With Nicotine Form in Adult Smokers
A Phase 1 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT04262817 is a Phase 1 study that has completed, run by Yale University. The registered enrollment target is 20 participants.
The verdict
NCT04262817, a Phase 1 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study seeks to elucidate the impact of e-cigarette flavor on subjective effects and nicotine exposure from e-cigarettes containing different forms of nicotine.
Interventions
- DRUG Nicotine form
- OTHER E-cigarette experimental flavor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2022-02-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04262817
The ClinicalTrials.gov registry entry for NCT04262817 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicotine form is the first listed.
NCT04262817 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04262817 about?
NCT04262817 is a clinical study titled "The Interaction of Flavor With Nicotine Form in Adult Smokers". This study seeks to elucidate the impact of e-cigarette flavor on subjective effects and nicotine exposure from e-cigarettes containing different forms of nicotine.
What is the current status of trial NCT04262817?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2020-11-01. Estimated completion is 2022-02-02.
What interventions are being tested in trial NCT04262817?
The interventions under investigation include: Nicotine form (DRUG), E-cigarette experimental flavor (OTHER).
Who is sponsoring clinical trial NCT04262817?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.